Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper
Jean L. Wright(University of North Carolina at Chapel Hill), George Rodrigues(London Health Sciences Centre), Raymond B. Mailhot Vega(University of Florida), Samantha Dawes(American Society for Radiation Oncology), Randi Kudner(American Society for Radiation Oncology), Sue S. Yom(University of California, San Francisco), Benjamin W. Fischer‐Valuck(Emory University), Musaddiq Awan
Cited by 77
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Head and neck cancer
|The Lancet|2021|829
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673